BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marques TM, Van Rumund A, Kuiperij HB, Verbeek MM. Biomarkers in cerebrospinal fluid for synucleinopathies, tauopathies, and other neurodegenerative disorders. Cerebrospinal Fluid in Neurologic Disorders. Elsevier; 2018. pp. 99-113. [DOI: 10.1016/b978-0-12-804279-3.00007-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Marques TM, van Rumund A, Bruinsma IB, Wessels HJCT, Gloerich J, Esselink RAJ, Bloem BR, Kuiperij HB, Verbeek MM. Cerebrospinal Fluid Galectin-1 Levels Discriminate Patients with Parkinsonism from Controls. Mol Neurobiol 2019;56:5067-74. [PMID: 30465235 DOI: 10.1007/s12035-018-1426-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Xiao Y, Chen H, Liao J, Zhang Q, He H, Lei J, Huang J, Ouyang Q, Shen Y, Wang J. The Potential Circular RNAs Biomarker Panel and Regulatory Networks of Parkinson’s Disease. Front Neurosci 2022;16:893713. [DOI: 10.3389/fnins.2022.893713] [Reference Citation Analysis]